Researchers have devised a way to communicate the effects of taking the new Alzheimer’s medications in language that is accessible and understandable to patients and their families. Using data on the natural history of the disease and the magnitude of the drugs’ effects as measured in clinical trials, the researchers calculated how many months of independent living an Alzheimer’s patient could expect to gain by undergoing treatment.